検索
MoonLake Immunotherapeutics
MLTXウォッチリストに追加
18.440USD
-0.550-2.90%
終値 07-31 16:00（ET）15分遅れの株価
1.52B時価総額
損失額直近12ヶ月PER
詳細情報 MoonLake Immunotherapeutics 企業名
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
MoonLake Immunotherapeuticsの企業情報
企業コードMLTX
会社名MoonLake Immunotherapeutics
上場日Oct 20, 2020
最高経営責任者「CEO」Santos Da Silva (Jorge)
従業員数100
証券種類Ordinary Share
決算期末Oct 20
本社所在地Dorfstrasse 29
都市ZUG
証券取引所NASDAQ OMX - NASDAQ BASIC
国Switzerland
郵便番号6300
電話番号41415108022
ウェブサイトhttps://moonlaketx.com/
企業コードMLTX
上場日Oct 20, 2020
最高経営責任者「CEO」Santos Da Silva (Jorge)
MoonLake Immunotherapeuticsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
よくある質問
MoonLake Immunotherapeuticsの上位5名の株主は誰ですか？
MoonLake Immunotherapeuticsの上位5名の株主は以下のとおりです。Dr. Kristian Reich
MoonLake Immunotherapeutics（MLTX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、MoonLake Immunotherapeuticsの株式を保有している機関は358社あり、保有株式の総市場価値は約54.44Mで、全体の74.73%を占めています。2025Q4と比較して、機関の持ち株は-3151979.00増加しています。